跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,367 条关于
“BKPyV nephropathy”
全部
3,367
临床试验
3,058
药物
23
机构
5
资讯
281
9个月前
Memo Therapeutics' Potravitug Receives EU Orphan Designation for BK Polyomavirus Infection in Kidney Transplant Patients
8个月前
Memo Therapeutics Publishes First Study Mapping BK Polyomavirus Impact on Kidney Transplant Recipients' Quality of Life
3个月前
Potravitug Demonstrates Statistically Significant Viral Clearance in Phase II BK Polyomavirus Trial, Paving Way for Pivotal Phase III
去年
Memo Therapeutics to Present Phase II Results for First-in-Class BK Polyomavirus Treatment at World Transplant Congress
2个月前
Ipsen to Acquire Memo Therapeutics in Deal Worth Over €700 Million, Securing Phase II BK Polyomavirus Antibody Potravitug
7个月前
Memo Therapeutics Partners with CSL in $328 Million Deal for Recombinant Polyclonal IgG Technology
去年
FDA Grants Breakthrough Therapy Designation to OMS721 for IgA Nephropathy
去年
Renalys Pharma Completes Enrollment in Phase III Trial of Sparsentan for IgA Nephropathy in Japan
去年
Felzartamab Shows Promise in Reducing Proteinuria in IgA Nephropathy Patients
去年
IgA Nephropathy Pipeline Shows Robust Growth with 30+ Therapies in Development
第 1 页,共 29 页
上一页
下一页